Dr. Abidi Pharmaceuticals (PJSC) successfully achieved the first rank in the pharmaceutical industry and the ninth rank in the overall capital market during the one-year period ending in September 2024 (Shahrivar 1403).

In this scoring and ranking evaluation, Dr. Abidi Pharmaceuticals achieved a flawless score of 100 in Corporate Governance and an outstanding score of 93.31 in Information Transparency.

The top issuers were evaluated from a pool of 542 listed companies based on rigorous scoring guidelines across 3 primary categories: Information Transparency, Corporate Governance, and Contribution to Capital Market Development.

As a member of Cobel Group, we remain steadfastly committed to integrity and transparency in our relationships with all stakeholders. Accordingly, since our entry into the capital market, we have held ourselves to the highest standards of accurate and transparent reporting. We continuously strive to further solidify the trust of market participants and shareholders by strictly adhering to shareholders’ rights and the core principles of corporate governance.